NorthStar Asset Management (Massachusetts)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Sell
175
-98
-36% -$100K 0.06% 88
2026
Q1
$251K Hold
273
– – 0.08% 78
2025
Q4
$293K Buy
+273
New +$261K 0.08% 72

Other funds holding LLY

NorthStar Asset Management (Massachusetts)'s LLY Position: Q2 2026 in Review

NorthStar Asset Management (Massachusetts) reduced its Eli Lilly (LLY) stake by 36% in Q2 2026, selling an estimated $100K and leaving 175 shares worth $210K. The position accounts for 0.06% of the portfolio, ranked #88.

NorthStar Asset Management (Massachusetts) first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $293K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NorthStar Asset Management (Massachusetts) held 175 shares of Eli Lilly worth $210K as of Q2 2026.
  • NorthStar Asset Management (Massachusetts) sold 98 Eli Lilly shares in Q2 2026, an estimated $100K.
  • Eli Lilly made up 0.06% of NorthStar Asset Management (Massachusetts)'s portfolio in Q2 2026, its #88 holding.
  • NorthStar Asset Management (Massachusetts) first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • NorthStar Asset Management (Massachusetts)'s Eli Lilly position peaked at $293K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NorthStar Asset Management (Massachusetts)'s 13F filing for Q2 2026, filed 28 Jul 2026.